z-logo
Premium
Comparison of two ultrashort echo time sequences for the quantification of T 1 within phantom and human Achilles tendon at 3 T
Author(s) -
Wright Peter,
Jellus Vladimir,
McGonagle Dennis,
Robson Matthew,
Ridgeway John,
Hodgson Richard
Publication year - 2012
Publication title -
magnetic resonance in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.696
H-Index - 225
eISSN - 1522-2594
pISSN - 0740-3194
DOI - 10.1002/mrm.24130
Subject(s) - achilles tendon , tendon , imaging phantom , asymptomatic , nuclear medicine , medicine , nuclear magnetic resonance , materials science , biomedical engineering , physics , anatomy , surgery
Ultrashort echo time (UTE) techniques enable direct imaging of musculoskeletal tissues with short T 2 allowing measurement of T 1 relaxation times. This article presents comparison of optimized 3D variable flip angle UTE (VFA‐UTE) and 2D saturation recovery UTE (SR‐UTE) sequences to quantify T 1 in agar phantoms and human Achilles tendon. Achilles tendon T 1 values for asymptomatic volunteers were compared to Achilles tendon T 1 values calculated from patients with clinical diagnoses of spondyloarthritis (SpA) and Achilles tendinopathy using an optimized VFA‐UTE sequence. T 1 values from phantom data for VFA‐ and SR‐UTE compare well against calculated T 1 values from an assumed gold standard inversion recovery spin echo sequence. Mean T 1 values in asymptomatic Achilles tendon were found to be 725 ± 42 ms and 698 ± 54 ms for SR‐ and VFA‐UTE, respectively. The patient group mean T 1 value for Achilles tendon was found to be 957 ± 173 ms ( P < 0.05) using an optimized VFA‐UTE sequence with pulse repetition time of 6 ms and flip angles 4, 19, and 24°, taking a total 9 min acquisition time. The VFA‐UTE technique appears clinically feasible for quantifying T 1 in Achilles tendon. T 1 measurements offer potential for detecting changes in Achilles tendon due to SpA without need for intravenous contrast agents. Magn Reson Med, 2012. © 2012 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here